Hostname: page-component-5c6d5d7d68-7tdvq Total loading time: 0 Render date: 2024-08-27T18:10:32.323Z Has data issue: false hasContentIssue false

Comparison of Staging Methods for Treatment-Resistant Depression: Chart Review

Published online by Cambridge University Press:  27 August 2024

K. B. Avanoğlu*
Affiliation:
1Psychiatry, Yalova State Hospital, Yalova
N. Oktar Erdoğan
Affiliation:
2Psychiatry, Pamukkale University Faculty of Medicine, Denizli
E. Ağaoğlu
Affiliation:
3Psychiatry, Bahçelievler Medipol Hospital, İstanbul
K. Başar
Affiliation:
4Psychiatry, Hacettepe University, Faculty of Medicine, Ankara, Türkiye
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Treatment-resistant depression (TRD) lacks a universally consistent definition due to varied interpretations despite attempts to define it based on inadequate response or remission despite sufficient antidepressant treatment. There’s a crucial demand for a uniform definition and staging to streamline its effective management amid diverse treatment options and the complex nature of resistance. Five methods have emerged to define and classify treatment resistance reliably.

Objectives

The aim of this study is to compare the five staging methods (Thase&Rush SM (T&R), European Staging Method (ESM), Maudsley Staging Method (MSM), Massachusetts General Hospital Staging Method (MHG-s), Conway Staging Method(Conway)) in assessing treatment resistance within a single sample.

Methods

Retrospective analysis involved medical records of inpatient psychiatry clinic admissions at Hacettepe University between October 2012 and October 2014. Patients with a primary diagnosis of bipolar affective disorder, schizophrenia, other chronic psychotic disorders, dementia or cognitive disorders, alcohol and substance use disorders, and those with missing data were excluded.

Results

Initial screening yielded a total of 115 patients. 64 patients were included in the study, 13 patients were excluded due to missing data, and 38 patients were excluded due to comorbidity.

CharacteristicTotal (N=64)Last Episode CharacteristicsTotal (N=64)
Female - N(%)44 (69)Episode duration – month (mean ± SD)13.75 ± 16.09
Age – yr (mean ± SD)48.39 ± 18.81Psychotic symptoms – N(%)20 (31)
Married – N(%)41 (64)Anxiety symptoms – N(%)24 (38)
Secondary school and over – N(%)38 (59)Suicidal attempt – N(%)19 (30)
Employed – N(%)16 (25)
TRD definition and staging method (N=55)T&RESMMSMMGH-SConway
Not resistant by this method26 (47.3)45 (81.8)0 (0)27 (49.1)43 (78.2)
Identified by this method29 (52.7)10 (18.2)55 (100)28 (50.9)12 (21.8)
Exclusively identified by this method0 (0)0 (0)21 (38.2)0 (0)0 (0)
By this and one other method27 (49.1)0 (0)11 (20)5 (9.1)0 (0)
By all methods10 (18.2)10 (18.2)10 (18.2)10 (18.2)10 (18.2)
Identified as TRD
Age of onset (mean ± SD)40.28 ± 17.4235.6 ± 18.2740.44 ±18.3840.07 ± 17.938.17 ± 17.71
ATHF score (mean ± SD)7.55 ± 5.4612.1 ± 6.514.93 ± 4.987.43 ± 5.6911.08 ± 6.47
Last episode duration (month) (mean ± SD)17.11 ± 17.2522.10 ± 20.9614.22 ± 17.0816.33 ± 17.6620.83 ± 19.25

Conclusions

There is no universally agreed-upon definition for treatment resistance. In this sample, different definition and staging methods were employed to examine the similarities and differences in the clinical and treatment related characteristics of groups with TRD identified with each. The reasons and possible implication of concurrence and discordance between the methods will be discussed.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.